Biodesix, Inc. BDSX Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Biodesix, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biodesix, Inc.'s accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biodesix, Inc.'s accounts receivable?
- Biodesix, Inc. (BDSX) reported accounts receivable of $9.5M in Q1 2026.
- How has Biodesix, Inc.'s accounts receivable changed year-over-year?
- Biodesix, Inc.'s accounts receivable increased by 24.4% year-over-year, from $7.64M to $9.5M.
- What is the long-term trend for Biodesix, Inc.'s accounts receivable?
- Over 5 years (2020 to 2025), Biodesix, Inc.'s accounts receivable has grown at a -10.0% compound annual growth rate (CAGR), from $15.3M to $9.04M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.